Charles river laboratories announces plasmid manufacturing collaboration with fondazione telethon

Wilmington, mass.--(business wire)--charles river laboratories international, inc. (nyse: crl), today announced a high quality (hq) plasmid manufacturing collaboration with fondazione telethon. the rare disease organization will leverage charles river's market leading cell and gene contract development and manufacturing organization (cdmo) expertise in high quality (hq) plasmid dna production, and good manufacturing practice- (gmp) compliant plasmid dna batches to manufacture hq plasmid dna for.
CRL Ratings Summary
CRL Quant Ranking